SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 37,650
+800 (2.17%)
At close: Aug 14, 2026
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 2.95 trillion as of August 14, 2026. Its market cap has decreased by -17.97% in one year.
Market Cap
2.95T
Enterprise Value
2.85T
Revenue
665.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
37,650.00
ChartMarket Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 2.95T, a decrease of -77.15%. That is a compound annual growth rate of -23.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.95T | -21.82% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.84T |
| HLB Co., Ltd. | 5.74T |
| ABL Bio | 4.71T |
| Peptron | 4.52T |
| LigaChem Biosciences | 4.20T |
| Voronoi | 3.23T |
| D&D Pharmatech | 2.81T |
| Hugel | 2.77T |